The Peptide Supply Chain Gap

Peptide therapies are reshaping modern healthcare, but the systems built to regulate and distribute them haven’t always kept pace. As clinical demand accelerated, providers, pharmacies, and regulators were forced to navigate a rapidly evolving supply chain landscape shaped by compounding rules, sourcing uncertainty, and emerging compliance challenges. This whitepaper explores how the peptide market reached its current state, and what the future of regulated peptide sourcing may look like for modern healthcare organizations.